The world’s Largest Sharp Brain Virtual Experts Marketplace Just a click Away
Levels Tought:
Elementary,Middle School,High School,College,University,PHD
| Teaching Since: | May 2017 |
| Last Sign in: | 402 Weeks Ago |
| Questions Answered: | 66690 |
| Tutorials Posted: | 66688 |
MCS,PHD
Argosy University/ Phoniex University/
Nov-2005 - Oct-2011
Professor
Phoniex University
Oct-2001 - Nov-2016
Performing ratio analysis using real-world data
Merck & Company is one of the world’s largest pharmaceutical companies. The following data were taken from the company’s 2007 annual report.
|
Fiscal Years Ending |
||
| Â |
December 31, 2007 |
December 31, 2006 |
|
Net earnings (in millions) |
$3,275.4 |
$4,433.8 |
|
Earnings per share |
$1.51 |
$2.04 |
The following data were taken from public stock-price quotes.
|
Stock price per share on March 3, 2008: $44.06 |
|
(Two months after the end of Merck’s 2007 fiscal year.) |
|
Stock price per share on March 1, 2007: $43.99 |
|
(Two months after the end of Merck’s 2007 fiscal year.) |
Required
a. Compute Merck’s price-earnings ratio for March 3, 2008, and March 1, 2007.
b. Did the financial markets appear to be more optimistic about Merck’s future performance on March 1, 2007, or March 3, 2008?
c. Based on the information provided, estimate approximately how many shares of stock Merck had outstanding as of December 31, 2007.
Hel-----------lo -----------Sir-----------/Ma-----------dam----------- Â----------- -----------Tha-----------nk -----------You----------- fo-----------r u-----------sin-----------g o-----------ur -----------web-----------sit-----------e a-----------nd -----------acq-----------uis-----------iti-----------on -----------of -----------my -----------sol-----------uti-----------on.-----------Ple-----------ase----------- pi-----------ng -----------me -----------on -----------cha-----------t I----------- am----------- on-----------lin-----------e o-----------r i-----------nbo-----------x m-----------e a----------- me-----------ssa-----------ge -----------I w-----------ill----------- be----------- ca-----------tch-----------